Economic aspects of commercial manufacture of biopharmaceuticals

This publication has 10 references indexed in Scilit:

• 4.2 Validation of Downstream Processes
  Published by Walter de Gruyter GmbH ,2011
• Effect of Shear Stress on Intrinsic CHO Culture State and Glycosylation of Recombinant Tissue-Type Plasminogen Activator Protein
  Biotechnology Progress, 2008
• Current status of antibody therapy for breast cancer
  Breast Cancer, 2004
• Expression Systems for the Production of Recombinant Pharmaceuticals
  BioDrugs, 2004
• History of antibody therapy for non-Hodgkin’s lymphoma
  Seminars in Oncology, 2003
• Improving Natural Principles with Genetic Engineering: TNK-Tissue Plasminogen Activator
  Arzneimittelforschung, 2001
• Transgenic manufactured biopharmaceuticals: a new method of drug manufacturing
  Expert Opinion on Investigational Drugs, 1999
• The position of the structurally autonomous kringle 2 domain influences the functional features of tissue-type plasminogen activator
  Protein Engineering, Design and Selection, 1995
• Effect of Culture Conditions on IgM Antibody Structure, Pharmacokinetics and Activity
  Bio/Technology, 1993
• Kringle glycosylation in a modified human tissue plasminogen activator improves functional properties
  Blood, 1993